EVALUATION OF RESPONSE TO SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO UDCA: A PILOT STUDY OF LIVER BIOPSIES FOLLOW UP Alejandra Villamil; Daniela de la Viña; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi;

OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS? Daniela De La Viña; Natalia Sobenko; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi; Maria Alejandra Villamil;

P-129 LIVER TRANSPLANTATION IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. EXPERIENCE OF TWO CASES AT AN ARGENTINE HHT REFERRAL CENTER Marcelo Serra; Juan Manuel Diaz; Anibal Arias; Martín De Santibañes; Eduardo De Santibañes; Juan Carlos Bandi;